Design Therapeutics Shares Are Trading Higher After Piper Sandler Upgraded the Stock From Neutral to Overweight and Raised Its Price Target From $6 to $12.
Design Therapeutics Shares Are Trading Higher After Piper Sandler Upgraded the Stock From Neutral to Overweight and Raised Its Price Target From $6 to $12.
派珀·桑德勒將該股從中性上調至增持，並將目標股價從6美元上調至12美元后，Design Therapeutics的股價走高。
Design Therapeutics Shares Are Trading Higher After Piper Sandler Upgraded the Stock From Neutral to Overweight and Raised Its Price Target From $6 to $12.
派珀·桑德勒將該股從中性上調至增持，並將目標股價從6美元上調至12美元后，Design Therapeutics的股價走高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。